Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1974 1
1976 3
1977 1
1979 2
1981 2
1982 5
1983 7
1984 4
1985 7
1986 9
1987 3
1988 7
1989 7
1990 7
1991 5
1992 7
1993 8
1994 7
1995 4
1996 7
1997 3
1998 7
1999 2
2000 4
2001 4
2002 5
2003 7
2004 9
2005 4
2006 10
2007 5
2008 9
2009 3
2010 5
2011 8
2012 9
2013 4
2014 3
2015 5
2016 8
2017 6
2018 5
2019 3
2020 1
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

222 results
Results by year
Filters applied: . Clear all
Page 1
Uveal melanoma: From diagnosis to treatment and the science in between.
Chattopadhyay C, Kim DW, Gombos DS, Oba J, Qin Y, Williams MD, Esmaeli B, Grimm EA, Wargo JA, Woodman SE, Patel SP. Chattopadhyay C, et al. Among authors: grimm ea. Cancer. 2016 Aug 1;122(15):2299-312. doi: 10.1002/cncr.29727. Epub 2016 Mar 15. Cancer. 2016. PMID: 26991400 Free PMC article. Review.
High-Throughput Architecture for Discovering Combination Cancer Therapeutics.
Gianni M, Qin Y, Wenes G, Bandstra B, Conley AP, Subbiah V, Leibowitz-Amit R, Ekmekcioglu S, Grimm EA, Roszik J. Gianni M, et al. Among authors: grimm ea. JCO Clin Cancer Inform. 2018 Dec;2:1-12. doi: 10.1200/CCI.17.00054. JCO Clin Cancer Inform. 2018. PMID: 30652536 Free PMC article.
Targeting iNOS to increase efficacy of immunotherapies.
Ekmekcioglu S, Grimm EA, Roszik J. Ekmekcioglu S, et al. Among authors: grimm ea. Hum Vaccin Immunother. 2017 May 4;13(5):1105-1108. doi: 10.1080/21645515.2016.1276682. Epub 2017 Jan 25. Hum Vaccin Immunother. 2017. PMID: 28121247 Free PMC article.
Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitor Responses in KIT-Mutant Metastatic Melanoma.
McKean M, Oba J, Ma J, Roth KG, Wang WL, Macedo MP, Carapeto FCL, Haydu LE, Siroy AE, Vo P, Hong DS, Eterovic AK, Patel KP, Bassett RL Jr, Grimm EA, Lazar AJ, Woodman SE. McKean M, et al. Among authors: grimm ea. J Invest Dermatol. 2019 Mar;139(3):728-731. doi: 10.1016/j.jid.2018.10.009. Epub 2018 Oct 25. J Invest Dermatol. 2019. PMID: 30798855 Free article. No abstract available.
Hypoxia-Driven Mechanism of Vemurafenib Resistance in Melanoma.
Qin Y, Roszik J, Chattopadhyay C, Hashimoto Y, Liu C, Cooper ZA, Wargo JA, Hwu P, Ekmekcioglu S, Grimm EA. Qin Y, et al. Among authors: grimm ea. Mol Cancer Ther. 2016 Oct;15(10):2442-2454. doi: 10.1158/1535-7163.MCT-15-0963. Epub 2016 Jul 25. Mol Cancer Ther. 2016. PMID: 27458138 Free PMC article.
Targeting the HGF/MET Axis Counters Primary Resistance to KIT Inhibition in KIT-Mutant Melanoma.
Oba J, Kim SH, Wang WL, Macedo MP, Carapeto F, McKean MA, Van Arnam J, Eterovic AK, Sen S, Kale CR, Yu X, Haymaker CL, Routbort M, Haydu LE, Bernatchez C, Lazar AJ, Grimm EA, Hong DS, Woodman SE. Oba J, et al. Among authors: grimm ea. JCO Precis Oncol. 2018;2018:PO.18.00055. doi: 10.1200/PO.18.00055. Epub 2018 Jun 5. JCO Precis Oncol. 2018. PMID: 30094412 Free PMC article. No abstract available.
IL-10: Expanding the Immune Oncology Horizon.
Chan IH, Wu V, McCauley S, Grimm EA, Mumm JB. Chan IH, et al. Among authors: grimm ea. Receptors Clin Investig. 2015;2(4):1041. Epub 2015 Nov 4. Receptors Clin Investig. 2015. PMID: 26661378 Free PMC article.
222 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page